Natural peptides in blood pressure control. A review

Agro Food Industry Hi-Tech

Volumn 16, Issue 5, 2005, Pages 15-17

  Muir, Alister D ^a  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE THERAPY; BIOACTIVE PEPTIDES; BUSINESS OPPORTUNITIES; FUNCTIONAL FOODS; HEALTH CONDITION; HEALTH PRODUCTS; HIGH BLOOD PRESSURES; MEDICAL CONDITIONS;

PEPTIDES;

BLOOD PRESSURE;

ANIMALIA; BRASSICA NAPUS VAR. NAPUS; LINUM USITATISSIMUM; SINAPIS ARVENSIS; TRITICUM AESTIVUM;

EID: 29844434309     PISSN: 17226996     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. R. Collins et al., "Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context", The Lancet, 335, pp. 827-838 (1990)
2. S. MacMahon et al., "Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias", The Lancet, 335, pp. 765-774 (1990)
3. R.J. Fitzgerald et al., "Hypotensive peptides from milk proteins", J. Nutr., 134, pp. 980S-988S.(2004)
4. S. Maruyama, H. Suzuki, "A peptide inhibitor of angiotensin I converting enzyme in the tryptic hydrolyzate of casein", Agric. Biol. Chem., 46, pp. 1393-1394 (1982)
5. S. Maruyama et al., "Angiotensin-convertign enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin- potentiating activity on the uterus and ileum of rats", Agric. Biol. Chem., 49, pp. 1405-1409 (1985)
6. N. Yamamoto et al., "Biogenic peptides and their potential use", Current Pharmaceutical Design, 9, pp. 1345-1355 (2003)
7. T. Matsui et al., "Preparation and characterization of novel bioactive peptides responsible for Angiotensin i-converting enzyme inhibition for wheat germ", J. Peptide Sci., 5, pp. 289-297 (1999)
8. J. Wu, X. Ding, "Hypotensive and Physiological Effect of Angiotensin Converting Enzyme Inhibitory Peptides Derived from Soy Protein on Spontaneously Hypertensive Rats", J. Agric. Food Chem., 49, pp. 501-506 (2001)
9. J. Wu et al., ACE inhibitory peptides from plant materials, in PCT WO 2004/057976 A1. 2003.
10. M. Sato et al., "Antihypertensive effects of hydrolysates of Wakame (Undaria pinnatifida) and their Angiotension-1-converting enzyme inhibitory activity", Ann. Nutr. Metabol., 46, pp. 259-267 (2002)
11. Y. Nakamura et al., "Purification and Characterization of Angiotensin I-Converting Enzyme Inhibitors from Sour Milk", J. Dairy Sci., 1995.
12. D.W. Cushman, H.S. Cheung, "Spetrophotometric assay and properties of the angiotensin I-converting enzyme of rabbit lung", Biochem. Pharmacol., 20, pp. 1637-1648 (1971)
13. J. Wu et al., "Improved method for direct high-performance liquid Chromatographic assay of angiotensin-converting enzyme-catalyzed reactions", J. Chrom., 950, pp. 125-130 (2002)
14. H. Karaki et al., "Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats", Comp. Biochem. Physiol. C., 96(2), pp. 367-371 (1990)
15. S. Sekiya et al., "Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hyertensive volunteers", J. Jpn. Soc. Nutr. Food Sci., 45, pp. 513-517 (1992)
16. Y. Hata et al., "A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects", Am. J. Clin. Nutr., 64, pp. 767-771 (1996)
17. L. Seppo et al., "A fermented milk high in bioactive peptides has a blood pressure - lowering effect in hypertensive subjects", Am. J. Clin. Nutr., 77, pp. 326-330 (2003)
18. J. Tuomilehto et al., "Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension", J. Hum. Hyperten., 18(11), pp. 795-802 (2004)
19. O. Masuda et al., "Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats", J. Nutr., 126, pp. 3063-3068 (1996)
20. S. Miyoshi et al., "Hypotensive activity of enyzmatic a-Zein hydrolysate", Agric. Biol. Chem., 55, pp. 1407-1408 (1991)
21. V. Vermeirssen et al., "Angiotensin-I Converting Enzyme (ACE) inhibitory peptides derived from pea and whey protein", Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet, 67(4), pp. 27-30 (2002)
22. Z.-I. Shin et al., "His-His-Leu, an Angiotensin I Converting Enzyme Inhibitory Peptide Derived from Korean Soybean Paste, Exerts Antihypertensive Activity in Vivo", J. Agric. Food Chem., 49, pp. 3004-3009 (2001)
23. E. Samacchi, M. Gobbetti, "Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme", Enzyme Microb. Technol., 22, pp. 687-694 (1998)
24. S.S. Haileselassie et al., "Purification and Identification of Potentially Bioactive Peptides from Enzyme-Modified Cheese", J. Dairy Sci., 82, pp. 1612-1617 (1995)
25. R.R. Townsend et al., "A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension", Am J. Hyper, 17(11 Pt 1), pp. 1056-1058 (2004)
26. Section 201(g)(1) Federal Food, Drug, and Cosmetic Act {21 U.S.C. 321(g)(1)?